Sonnet Biotherapeutics (SONN) Q1 2025 Earnings

Feb 13Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-6.12
-4.06
-1.99
0.07

Details

Expected EPS
-1.39
Actual EPS
-1.56
Surprise EPS
-0.17
Surprise Percent
-12.23%

Description

⁨Sonnet Biotherapeutics⁩ (⁦SONN⁩) has reported earnings of ⁦-1.56⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts